Innovation Theaters

September 30 - October 2


Please join us to learn about an FDA-approved first line monotherapy option in advanced NSCLC
Nagla Karim, MD
Thursday, September 30 at 2:10 PM Eastern
Presented by:


Takeda Oncology Lung Targeted Therapy Presentation
Martin Dietrich, MD, PhD
Friday, October 1 at 10:35 AM Eastern
Presented by:


Exploring a Treatment Option for Patients With Previously Treated Metastatic Small Cell Lung Cancer (SCLC)
Eric Nadler, MD, MPP
Friday, October 1 at 1:05 PM Eastern
Presented by:


Transforming the Treatment of NSCLC: Options for Treatment of Resectable Disease and Treatment of Unresectable Stage III Disease
Tarek Mekhail, MD, MSc, FRCSI, FRCSEd
Saturday, October 2 at 10:55 AM Eastern
Presented by:

 

This Innovation Theater is available during Personalized Therapies in Thoracic Oncology. The opinions and recommendations expressed do not necessarily reflect the views of the Personalized Therapies in Thoracic Oncology, Imedex, HMP Global or NACCME. This program is not intended or eligible for continuing education (CME/CE) credits and does not meet guidelines governing CME/CE. By viewing this Innovation Theater, you opt-in to share/receive information with/from industry sponsors. If you wish to opt-out, email: optouts@thoraciccancermeeting.com